JP2012191948A
|
|
Vaccine and vaccine protein using sendai virus vector
|
JP2009268471A
|
|
Vaccine and vaccine protein using sendai virus vector
|
CN101351557A
|
|
Gene transfer into airway epithelial stem cell by using lentiviral vector pseudotyped with RNA virus or DNA virus spike protein
|
JP2006051036A
|
|
Recombinant sendai virus
|
CA2571844A1
|
|
Anticancer agent containing minus-strand rna virus
|
WO2005097988A1
|
|
Bone marrow-relevant cell participating the maintenance and/or repair of tissue
|
CA2560046A1
|
|
Methods for suppressing tumor proliferation
|
WO2005071085A1
|
|
Process for producing virus vector
|
KR20070004636A
|
|
METHOD OF PRODUCING MINUS STRAND RNA VIRUS VECTOR WITH THE USE OF HYBRID PROMOTER CONTAINING CYTOMEGALOVIRUS ENHANCER AND AVIAN beta;-ACTIN PROMOTER
|
KR20060129013A
|
|
Gene therapy for tumor using minus-strand rna virus vector encoding immunostimulating cytokine
|
JP2005102702A
|
|
Recombinant sendai virus
|
CA2544786A1
|
|
Method for producing gene transferred dendritic cells
|
WO2005035765A1
|
|
Method of inhibiting interferon response
|
KR20060028432A
|
|
Minus strand rna virus vector carrying gene modified in high mutation region
|
AU2004252010A1
|
|
Method for transplanting lymphohematopoietic cells into mammal
|
JP2004298192A
|
|
Negative strand rna viral vector having autonomous replication capability
|
JP2004254707A
|
|
Rna virus vector having contact infiltration ability
|
JP2004254708A
|
|
Recombinant sendai virus
|
JP2007254286A
|
|
METHOD FOR PROTECTING ORGAN BY TRANSFERRING Bcl-xL GENE
|
JP2007228802A
|
|
Method for transferring gene to target cell
|